stockcue

KROS (Keros Therapeutics, Inc.): risk score 57/100 — Hold · Valuation 60/100 · Financial health 80/100 · Growth 28/100 · price $11.39. Full report with peer comparison, earnings trends and AI analysis below.

Fetching report — first lookup can take ~5s